Wow — rofecoxib (Vioxx) was taken off the market today due to increased “cardiovascular events” (heart attacks and strokes, mainly). Chris Rangel has a good little ditty today on the deshelving, noting that it’s just part of a cycle that starts with overhyping, continues on to hemorrhaging health care dollars, and ends with multibillion dollar tort lawsuits. Makes doctors and lawyers happy to be part of their respective professional communities…